Accounts Receivable, after Allowance for Credit Loss, Current of Concord Medical Services Holdings Ltd from 31 Dec 2010 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD and CNY
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
Concord Medical Services Holdings Ltd quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD history and change rate from 31 Dec 2010 to 31 Dec 2024.
  • Concord Medical Services Holdings Ltd Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending 31 Dec 2024 was $7,010,000, a 32% decline year-over-year.
Concord Medical Services Holdings Ltd quarterly Accounts Receivable, after Allowance for Credit Loss, Current in CNY history and change rate from 31 Dec 2010 to 31 Dec 2024.
  • Concord Medical Services Holdings Ltd Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending 31 Dec 2024 was ¥51,168,000, a 30% decline year-over-year.
Source SEC data
View on sec.gov
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Change (%)
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (CNY)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Change (%)

Concord Medical Services Holdings Ltd Quarterly Accounts Receivable, after Allowance for Credit Loss, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $7,010,000 -$3,342,000 -32% 31 Dec 2024 20-F 25 Apr 2025 2024 FY
Q4 2023 $10,352,000 -$8,536,000 -45% 31 Dec 2023 20-F 19 Apr 2024 2023 FY
Q4 2022 $18,888,000 -$1,182,000 -5.9% 31 Dec 2022 20-F 19 Apr 2023 2022 FY
Q4 2021 $20,070,000 +$8,212,000 +69% 31 Dec 2021 20-F 29 Apr 2022 2021 FY
Q4 2020 $11,858,000 +$1,267,000 +12% 31 Dec 2020 20-F 15 Oct 2021 2020 FY
Q4 2019 $10,591,000 -$2,043,000 -16% 31 Dec 2019 20-F 30 Apr 2020 2019 FY
Q4 2018 $12,634,000 -$7,647,000 -38% 31 Dec 2018 20-F 30 Apr 2019 2018 FY
Q4 2017 $20,281,000 -$7,025,000 -26% 31 Dec 2017 20-F 30 Apr 2018 2017 FY
Q4 2016 $27,306,000 -$6,387,000 -19% 31 Dec 2016 20-F 01 May 2017 2016 FY
Q4 2015 $33,693,000 -$9,019,000 -21% 31 Dec 2015 20-F 28 Apr 2016 2015 FY
Q4 2014 $42,712,000 -$9,142,000 -18% 31 Dec 2014 20-F 27 Apr 2015 2014 FY
Q4 2013 $51,854,000 +$18,097,000 +54% 31 Dec 2013 20-F 28 Apr 2014 2013 FY
Q4 2012 $33,757,000 -$5,041,000 -13% 31 Dec 2012 20-F/A 08 May 2013 2012 FY
Q4 2011 $38,798,000 31 Dec 2011 20-F/A 16 May 2012 2011 FY

Concord Medical Services Holdings Ltd Quarterly Accounts Receivable, after Allowance for Credit Loss, Current (CNY)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 ¥51,168,000 -¥22,328,000 -30% 31 Dec 2024 20-F 25 Apr 2025 2024 FY
Q4 2023 ¥73,496,000 -¥56,775,000 -44% 31 Dec 2023 20-F 25 Apr 2025 2024 FY
Q4 2022 ¥130,271,000 +¥2,372,000 +1.9% 31 Dec 2022 20-F 19 Apr 2024 2023 FY
Q4 2021 ¥127,899,000 +¥50,524,000 +65% 31 Dec 2021 20-F 19 Apr 2023 2022 FY
Q4 2020 ¥77,375,000 +¥3,644,000 +4.9% 31 Dec 2020 20-F 29 Apr 2022 2021 FY
Q4 2019 ¥73,731,000 -¥13,137,000 -15% 31 Dec 2019 20-F 15 Oct 2021 2020 FY
Q4 2018 ¥86,868,000 -¥45,084,000 -34% 31 Dec 2018 20-F 30 Apr 2020 2019 FY
Q4 2017 ¥131,952,000 -¥57,637,000 -30% 31 Dec 2017 20-F 30 Apr 2019 2018 FY
Q4 2016 ¥189,589,000 -¥28,665,000 -13% 31 Dec 2016 20-F 30 Apr 2018 2017 FY
Q4 2015 ¥218,254,000 -¥46,756,000 -18% 31 Dec 2015 20-F 01 May 2017 2016 FY
Q4 2014 ¥265,010,000 -¥48,899,000 -16% 31 Dec 2014 20-F 28 Apr 2016 2015 FY
Q4 2013 ¥313,909,000 +¥103,602,000 +49% 31 Dec 2013 20-F 27 Apr 2015 2014 FY
Q4 2012 ¥210,307,000 -¥33,882,000 -14% 31 Dec 2012 20-F 28 Apr 2014 2013 FY
Q4 2011 ¥244,189,000 +¥74,800,000 +44% 31 Dec 2011 20-F/A 08 May 2013 2012 FY
Q4 2010 ¥169,389,000 31 Dec 2010 20-F/A 16 May 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.